参考文献/References:
[1] CRUZ-JENTOFT A J,BAHAT G,BAUER J,et al.Sarcopenia:revised European consensus on definition and diagnosis[J/OL].[2023-01-20].https://academic.oup.com/ageing/article/48/4/601/5488778?login=true.DOI:10.1093/ageing/afz046.
[2] 邓菲菲,赵智芳,李建琼,等.社区老年肌少症风险筛查工具与方法的研究进展 [J].军事护理,2023,40(5):82-85.
[3] 钟文,谢春光,高泓,等.糖尿病与肌少症关系研究新进展[J].中国糖尿病杂志,2017,25(7):662-665.
[4] 姜珊,康琳,刘晓红.2019亚洲肌少症诊断及治疗共识解读[J].中华老年医学杂志,2020,39(4):373-376.
[5] 陆金玲,许勤,花红霞,等.肌肉减少症筛查工具在老年人群中的研究进展[J].中国全科医学,2020,23(27):3444-3448.
[6] TANAKA T,TAKAHASHI K,AKISHITA M,et al.“Yubi-wakka”(finger-ring)test:a practical self-screening method for sarcopenia,and a predictor of disability and mortality among Japanese community-dwelling older adults[J].Geriatr Gerontol Int,2018,18(2):224-232.
[7] 温鹏天,张瑞丽,李慧娟,等.指环测试在社区老年人肌少症筛查中的应用[J].中华护理教育,2021,18(3):275-278.
[8] 黄丽洁,王飞杰,孟令弟,等.中文版SARC-F量表在社区老年人群中的应用研究[J].护理学杂志,2020,35(19):85-87.
[9] BARBOSA-SILVA T G,MENEZES A M B,BIELEMANN R M,et al.Enhancing SARC-F:improving sarcopenia screening in the clinical practice[J].J Am Med Dir Assoc,2016,17(12):1136-1141.
[10]陈姝,俞静,狄文娟,等.南京市社区老年肌少症流行病学调查及其影响因素分析[J].实用老年医学,2020,34(8):793-796.
[11]CHEN L K,WOO J,ASSANTACHAI P,et al.Asian Working Group for Sarcopenia:2019 consensus update on sarcopenia diagnosis and treatment[J].J Am Med Dir Assoc,2020,21(3):300-307.
[12]牛芳,冯丽媛,高倩倩,等.糖尿病患者肌少症患病率的Meta分析[J].中华糖尿病杂志,2022,14(5):448-455.
[13]黄倩,徐慧萍,张艳,等.社区慢性病共病老年患者肌少症筛查工具的比较研究[J].中华护理杂志,2022,57(24):3017-3021.
[14]王伟伊,马慧珍,李曼.2型糖尿病合并肌少症的发病机制、药物治疗及健康管理研究进展[J].山东医药,2022,62(2):97-100.
[15]吴丽娟,郭太林,李小明,等.亚洲地区老年2型糖尿病患者肌少症患病率和影响因素的Meta分析[J].中国糖尿病杂志,2020,28(9):651-656.
[16]吴佳佳,王炜,祝捷,等.2型糖尿病患者肌少症的相关因素[J].中华骨质疏松和骨矿盐疾病杂志,2016,9(2):129-135.
[17]CHENG Q,ZHU X Y,ZHANG X M,et al.A cross-sectional study of loss of muscle mass corresponding to sarcopenia in healthy Chinese men and women:reference values,prevalence,and association with bone mass[J].J Bone Miner Metab,2014,32(1):78-88.
[18]何清华,郭立新.重视老年糖尿病合并肌少症的防治与研究[J].中华糖尿病杂志,2023,15(1):1-5.
[19]WOO J,LEUNG J,MORLEY J E.Validating the SARC-F:a suitable community screening tool for sarcopenia[J].J Am Med Dir Assoc,2014,15(9):630-634.
[20]徐泽汝.SARC-F量表和SARC-CalF量表在2型糖尿病患者中筛查肌少症的应用研究[D].温州:温州医科大学,2022.
[21]YANG M,HU X,XIE L,et al.Screening sarcopenia in community-dwelling older adults:SARC-F vs SARC-F combined with calf circumference(SARC-CalF)[J/OL].[2023-01-20].https://linkinghub.elsevier.com/retrieve/pii/S1525-8610(17)30701-6.DOI:10.1016/j.jamda.2017.12.016.
相似文献/References:
[1]苏清清,孟俊华,库洪安,等.糖尿病自我管理决策辅助信息平台的构建与应用[J].军事护理,2021,38(04):13.[doi:10.3969/j.issn.1008-9993.2021.04.004]
SU Qingqing,MENG Junhua,KU Hongan,et al.Construction and Application of Self-management Decision Support Information Platform for Diabetics[J].Nursing Journal Of Chinese People's Laberation Army,2021,38(10):13.[doi:10.3969/j.issn.1008-9993.2021.04.004]
[2]幸维炜,周佩如,杨青,等.糖尿病患者病耻感与心理性胰岛素抵抗的现状及其影响因素[J].军事护理,2021,38(06):22.[doi:10.3969/j.issn.1008-9993.2021.06.006]
XING Weiwei,ZHOU Peiru,YANG Qing,et al.Status Quo of the Relationship between Stigma and Psychological Insulin Resistance in Diabetics and Its Influencing Factors[J].Nursing Journal Of Chinese People's Laberation Army,2021,38(10):22.[doi:10.3969/j.issn.1008-9993.2021.06.006]
[3]沈睿,王俊杰.抗阻运动在老年肌少症患者中的应用研究进展[J].军事护理,2023,40(10):84.[doi:10.3969/j.issn.2097-1826.2023.10.020]